# Marine Bioactive Compounds from Functional Seafoods: Pharmacological Mechanisms and Health Applications

**Authors:** Sena Davran Bulut, Naciye Yaktubay Döndaş, Senanur Koçhan, Beyza Nur Arslan, Mehmet Ali Tamer, Mirsade Osmani, Safa Baraketi, Khaoula Khwaldia, Ziye Zhang, Hacı Ali Döndaş, Tuba Esatbeyoglu, Panagiota Katikou, Fatih Ozogul

PMC · DOI: 10.3390/md24030116 · 2026-03-20

## TL;DR

Functional seafoods from marine sources offer health benefits through bioactive compounds and may help prevent chronic diseases, though challenges remain in their regulation and sustainability.

## Contribution

This review highlights pharmacological mechanisms and health applications of marine bioactive compounds while emphasizing the need for interdisciplinary research.

## Key findings

- Marine bioactive compounds show anti-inflammatory, antioxidant, and immunomodulatory effects.
- Functional seafoods may help manage chronic diseases like cardiovascular and neurodegenerative disorders.
- Sustainable aquaculture and biotechnology advancements are improving the quality and relevance of these compounds.

## Abstract

Functional seafoods derived from marine organisms, including fish, shellfish and algae, are gaining increasing attention due to their high content of bioactive compounds, such as omega-3 fatty acids, peptides, polysaccharides and antioxidants, which provide health benefits beyond basic nutrition. These marine-derived compounds exhibit a wide range of biological activities and have been investigated for their potential roles in the prevention and management of chronic diseases, including cardiovascular, neurodegenerative, cancer and gastrointestinal disorders. Their effects are largely mediated through anti-inflammatory, antioxidant and immunomodulatory mechanisms. Advances in biotechnology, including genetic engineering and improved extraction of bioactive compounds, have enhanced the nutritional quality and pharmacological relevance of functional seafoods. At the same time, sustainable aquaculture practices are being developed to reduce environmental impacts. Nevertheless, challenges such as regulatory inconsistencies, scalability issues and limited understanding of bioavailability and long-term effects still persist. These constraints should be considered when interpreting mechanistic and efficacy findings presented across different study designs and exposure conditions. Future perspectives highlight innovations in precision aquaculture, waste valorisation and traceability as key strategies to improve sustainability and strengthen consumer trust. This review summarizes current knowledge on functional seafoods, with emphasis on pharmacological mechanisms, clinical applications and the need for interdisciplinary research to optimize their health benefits and commercial potential.

## Linked entities

- **Chemicals:** omega-3 fatty acids (PubChem CID 56842239)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, DCK (deoxycytidine kinase) [NCBI Gene 1633], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}, EIF2A (eukaryotic translation initiation factor 2A) [NCBI Gene 83939] {aka CDA02, EIF-2A, MST089, MSTP004, MSTP089}, EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) [NCBI Gene 1915] {aka CCS-3, CCS3, EE1A1, EEF-1, EEF1A, EF-Tu}, Ache (acetylcholinesterase) [NCBI Gene 11423], APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, TAC1 (tachykinin precursor 1) [NCBI Gene 6863] {aka Hs.2563, NK2, NKNA, NPK, TAC2}, Chat (choline O-acetyltransferase) [NCBI Gene 12647] {aka B230380D24Rik, CHOACTase}
- **Diseases:** ischemia (MESH:D007511), motor neuron diseases (MESH:D016472), cephalalgia (MESH:D006261), Oxidative (MESH:D028361), reperfusion injury (MESH:D015427), diabetes (MESH:D003920), atherosclerotic (MESH:D050197), Gastrointestinal Diseases (MESH:D005767), Neurodegenerative Diseases (MESH:D019636), hematological toxicity (MESH:D006402), HD (MESH:D006816), gastritis (MESH:D005756), liposarcoma (MESH:D008080), cytotoxic (MESH:D064420), CVD (MESH:D002318), leukopenia (MESH:D007970), pain (MESH:D010146), neuroinflammation (MESH:D000090862), bone marrow suppression (MESH:D001855), neurotoxicity (MESH:D020258), anemia (MESH:D000740), cognitive impairments (MESH:D003072), PD (MESH:D010300), cardiac dysfunction (MESH:D006331), Gastrointestinal tract (GI) diseases (MESH:D005770), acute leukemia (MESH:D015470), constipation (MESH:D003248), obesity (MESH:D009765), learning and memory impairments (MESH:D007859), type 2 diabetes (MESH:D003924), leukemia (MESH:D007938), depression (MESH:D003866), carcinogenesis (MESH:D063646), degeneration of myelin (MESH:D003711), deaths (MESH:D003643), bone, back or joint (MESH:D001847), malnutrition (MESH:D044342), multiple myeloma (MESH:D009101), soft tissue sarcomas (MESH:D012509), abdominal pain (MESH:D015746), spinal muscular atrophy (MESH:D009134), nausea (MESH:D009325), injury to (MESH:D014947), prion diseases (MESH:D017096), ulcers (MESH:D014456), endometrial cancer (MESH:D016889), ovarian cancer (MESH:D010051), anxiety (MESH:D001007), acute non-lymphocytic leukemia (MESH:D054198), neuronal damage (MESH:D009410), thrombotic (MESH:D013927), Inflammatory (MESH:D007249), hematological malignancies (MESH:D019337), vomiting (MESH:D014839), arrhythmias (MESH:D001145), thrombocytopenia (MESH:D013921), asthenia (MESH:D001247), hypertension (MESH:D006973), diarrhea (MESH:D003967), breast cancer (MESH:D001943)
- **Chemicals:** diethylether (MESH:D004986), zinc (MESH:D015032), potassium (MESH:D011188), zeaxanthin (MESH:D065146), carotenoid (MESH:D002338), triglyceride (MESH:D014280), Polysaccharides (MESH:D011134), halichondrin B (MESH:C070519), doxorubicin (MESH:D004317), didemnin B. (MESH:C030051), lipid (MESH:D008055), norepinephrine (MESH:D009638), platinum (MESH:D010984), Chitosan (MESH:D048271), iron (MESH:D007501), beta-carotene (MESH:D019207), arginine (MESH:D001120), depsipeptide (MESH:D047630), laminarin (MESH:C008247), cerebrosides (MESH:D002554), Paclitaxel (MESH:D017239), E7389 (MESH:C490954), mercury (MESH:D008628), fatty acids (MESH:D005227), vitamin A (MESH:D014801), Adcetris (MESH:D000079963), fish oils (MESH:D005395), heavy metals (MESH:D019216), iodine (MESH:D007455), Calcium (MESH:D002118), anthracycline (MESH:D018943), PCBs (MESH:D011078), nitric oxide (MESH:D009569), omega-3-acid ethyl esters (MESH:C405603), Fucoxanthin (MESH:C025164), Peptic (-), cadmium (MESH:D002104), short-chain fatty acids (MESH:D005232), taxanes (MESH:D043823), glycine (MESH:D005998), Se (MESH:D012643), Cytarabine (MESH:D003561), glucose (MESH:D005947), alkaloid (MESH:D000470), carrageenan (MESH:D002351), alginate (MESH:D000464), chondroitin sulfate (MESH:D002809), oligosaccharides (MESH:D009844), EPA (MESH:D015118), cytidine (MESH:D003562), vitamin D (MESH:D014807), polyphenols (MESH:D059808), lipopolysaccharide (MESH:D008070), glutamate (MESH:D018698), dietary fat (MESH:D004041), Omega-3 fatty acids (MESH:D015525), Plitidepsin (MESH:C098980), peptides (MESH:D010455), glutathione (MESH:D005978), Trabectedin (MESH:D000077606)
- **Species:** Holothuroidea (holothurians, class) [taxon 7705], Limnospira platensis (species) [taxon 118562], Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606], Conus magus (magus cone, species) [taxon 6492], gut metagenome (species) [taxon 749906], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Halichondria okadai (species) [taxon 163232], Ulva prolifera (species) [taxon 3117], Mus musculus (house mouse, species) [taxon 10090], PX clade (clade) [taxon 569578], Undaria pinnatifida (species) [taxon 74381], Rhodophyta (red algae, phylum) [taxon 2763], Helicobacter pylori (species) [taxon 210], Cucumis sativus (cucumber, species) [taxon 3659], Auxenochlorella pyrenoidosa (species) [taxon 3078], Ecteinascidia turbinata (species) [taxon 284476], Phaeophyceae (brown algae, class) [taxon 2870], Rubroshorea almon (species) [taxon 292004], Rattus norvegicus (brown rat, species) [taxon 10116], Sardina pilchardus (European pilchard, species) [taxon 27697], Cyanobacteriota (blue-green algae, phylum) [taxon 1117], Gammacoronavirus (genus) [taxon 694013]
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027525/full.md

---
Source: https://tomesphere.com/paper/PMC13027525